CIK 0001764013
- Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832771572
- Phone
- +1 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $895,852
- in 9 filings, $173K under 10b5-1 plans
Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Venker Eric Chief Executive Officer | Sale | −3,506 | $34.11 | $120K | 257,075 |
| 2026-10-01 | Venker Eric Chief Executive Officer | Exercise or conversion | +92,187 | $14.46 | $1.3M | 346,467 |
| 2026-10-01 | Venker Eric Chief Executive Officer | Returned to the company | −85,886 | $33.65 | $2.9M | 260,581 |
| 2026-10-01 | Venker Eric Chief Executive Officer | Exercise or conversion · Capped Value Appreciation Rights | −92,187 | 921,875 | ||
| 2026-07-02 | Venker Eric Chief Executive Officer | Sale | −3,092 | $38.48 | $119K | 254,280 |
| 2026-07-01 | Venker Eric Chief Executive Officer | Exercise or conversion | +92,188 | $14.46 | $1.3M | 344,001 |
| 2026-07-01 | Venker Eric Chief Executive Officer | Returned to the company | −86,629 | $38.14 | $3.3M | 257,372 |
| 2026-07-01 | Venker Eric Chief Executive Officer | Exercise or conversion · Capped Value Appreciation Rights | −92,188 | 1,014,062 | ||
| 2026-04-07 | Venker Eric Chief Executive Officer | Grant or award | +232,252 | 251,813 | ||
| 2026-04-07 | Venker Eric Chief Executive Officer | Grant or award · Stock Option (right to buy) | +336,043 | 336,043 | ||
| 2026-04-02 | Venker Eric Chief Executive Officer | Sale | −12,820 | $24.04 | $308K | 20,970 |
| 2026-04-02 | Venker Eric Chief Executive Officer | Sale | −1,409 | $24.60 | $35K | 19,561 |
| 2026-04-01 | Venker Eric Chief Executive Officer | Exercise or conversion | +368,750 | $14.46 | $5.3M | 368,750 |
| 2026-04-01 | Venker Eric Chief Executive Officer | Returned to the company | −334,960 | $25.10 | $8.4M | 33,790 |
| 2026-04-01 | Venker Eric Chief Executive Officer | Exercise or conversion · Capped Value Appreciation Rights | −368,750 | 1,106,250 | ||
| 2025-07-28 | Venker Eric Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,300,000 | 1,300,000 | ||
| 2025-07-28 | Venker Eric Chief Executive Officer | Grant or award · Stock Option (right to buy) | +189,900 | 189,900 | ||
| 2025-07-28 | Venker Eric Chief Executive Officer | Grant or award · Capped Value Appreciation Rights | +1,475,000 | 1,475,000 |
Page 1 of 1 · 18 trades